Found: 3
Select item for more details and to access through your institution.
222-OR: BETA-2 Calculated Based on Single Fasting Blood Sample Allows to Define and Discriminate between Optimal and Suboptimal Islet Allograft Function Prior to the Clinical Need for Insulin Support.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-222-OR
- By:
- Publication type:
- Article
220-OR: Is There Any Prognostic Value of Diabetes-Associated Autoantibody Levels for Predicting Islet Graft Function in Patients with Long-Standing Type 1 Diabetes Mellitus?
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-220-OR
- By:
- Publication type:
- Article
218-OR: Does the Reparixin (CXCR1/2 Inhibitor) Improve Islet Cell Engraftment and Clinical Outcomes after Pancreatic Islet Allotransplantation in Patients with Type 1 Diabetes Mellitus? A Randomized, Double-Blind, Prospective Study.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-218-OR
- By:
- Publication type:
- Article